A human-like bile acid pool induced by deletion of hepatic Cyp2c70 modulates effects of FXR activation in mice[S] by de Boer, Jan Freark et al.
  
 University of Groningen
A human-like bile acid pool induced by deletion of hepatic Cyp2c70 modulates effects of FXR
activation in mice[S]
de Boer, Jan Freark; Verkade, Esther; Mulder, Niels L; de Vries, Hilde D; Huijkman, Nicolette
Ca; Koehorst, Martijn; Boer, Theo; Wolters, Justina C; Bloks, Vincent W; van de Sluis, Bart
Published in:
Journal of Lipid Research
DOI:
10.1194/jlr.RA119000243
IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from
it. Please check the document version below.
Document Version
Publisher's PDF, also known as Version of record
Publication date:
2020
Link to publication in University of Groningen/UMCG research database
Citation for published version (APA):
de Boer, J. F., Verkade, E., Mulder, N. L., de Vries, H. D., Huijkman, N. C., Koehorst, M., ... Kuipers, F.
(2020). A human-like bile acid pool induced by deletion of hepatic Cyp2c70 modulates effects of FXR
activation in mice[S]. Journal of Lipid Research, 61(3), 291-305. https://doi.org/10.1194/jlr.RA119000243
Copyright
Other than for strictly personal use, it is not permitted to download or to forward/distribute the text or part of it without the consent of the
author(s) and/or copyright holder(s), unless the work is under an open content license (like Creative Commons).
Take-down policy
If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately
and investigate your claim.
Downloaded from the University of Groningen/UMCG research database (Pure): http://www.rug.nl/research/portal. For technical reasons the
number of authors shown on this cover page is limited to 10 maximum.
Download date: 19-05-2020
This article is available online at http://www.jlr.org Journal of Lipid Research Volume 61, 2020 291
Copyright © 2020 de Boer et al. Published by The American Society for Biochemistry 
and Molecular Biology, Inc.
N. Huijkman, M. Koehorst, T. Boer, J. C. Wolters, V. W. Bloks, 
B. van de Sluis, and F. Kuipers. A human-like bile acid pool 
induced by deletion of hepatic Cyp2c70 modulates effects of 
FXR activation in mice. J. Lipid Res. 2020. 61: 291–305.





facilitate  solubilization  and  absorption  of  dietary  choles-
terol, fats, and fat-soluble vitamins in the small intestine 
(1). Whereas cholesterol  is  virtually not absorbed  in  the 
absence of BAs, fatty acid absorption decreases from 97% 
to 70% when no BAs are present within the intestinal lu-
men  (2).  The  capacity  to  solubilize  cholesterol,  but  also 
other  lipids,  in  the  intestine  is  largely determined by  the 
size and composition of the circulating BA pool that con-
sists of  several  species differing  in number, position, and 
orientation  of  hydroxyl  groups  (Table 1)  and  hence  in 
lipid-dissolving  properties  (1).  BAs  also  act  as  signaling 
molecules by activating  the nuclear  farnesoid X receptor 
(FXR; NR1H4) (3, 4) and the membrane-bound Takeda 
Abstract Bile acids (BAs) facilitate intestinal absorption of 
lipid-soluble nutrients and modulate various metabolic path-
ways through the farnesoid X receptor (FXR) and Takeda 
G-protein-coupled receptor 5. These receptors are targets 
for therapy in cholestatic and metabolic diseases. However, 
dissimilarities in BA metabolism between humans and mice 
complicate translation of preclinical data. Cytochrome P450 
family 2 subfamily c polypeptide 70 (CYP2C70) was recently 
proposed to catalyze the formation of rodent-specific muri-
cholic acids (MCAs). With CRISPR/Cas9-mediated somatic 
genome editing, we generated an acute hepatic Cyp2c70 knock-
out mouse model (Cyp2c70ako) to clarify the role of CYP2C70 
in BA metabolism in vivo and evaluate whether its activity 
modulates effects of pharmacologic FXR activation on cho-
lesterol homeostasis. In Cyp2c70ako mice, chenodeoxycholic 
acid (CDCA) increased at the expense of MCA, resulting in 
a more hydrophobic human-like BA pool. Tracer studies 
demonstrated that, in vivo, CYP2C70 catalyzes the forma-
tion of MCA primarily by sequential 6-hydroxylation and 
C7-epimerization of CDCA, generating MCA as an interme-
diate metabolite. Physiologically, the humanized BA compo-
sition in Cyp2c70ako mice blunted the stimulation of fecal 
cholesterol disposal in response to FXR activation compared 
with WT mice, predominantly due to reduced stimulation of 
transintestinal cholesterol excretion. Thus, deletion of he-
patic Cyp2c70 in adult mice translates into a human-like BA 
pool composition and impacts the response to pharmaco-
logic FXR activation.  This Cyp2c70ako mouse model may be a 
useful tool for future studies of BA signaling and metabolism 
that informs human disease development and treatment.—
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70; Cyp2c70ako,  cytochrome P450  family 2  subfamily c polypeptide 70 
acute knockout; DCA, deoxycholic  acid; LCA,  lithocholic  acid; MCA, 
muricholic acid; PX, PX20606; qPCR, quantitative PCR; sgRNA, single-
guide RNA; TGR5, Takeda G-protein-coupled receptor 5; TICE, tran-
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Moreover,  FXR  affects  several  aspects  of  glucose  and  






size,  cycling  frequency,  and  composition  of  the BA pool 
represent  important  factors  in maintenance of metabolic 
control. BA  signaling pathways are  therefore considered 
attractive  therapeutic  targets  for  treatment  of metabolic 
syndrome-associated  morbidities,  including  nonalcoholic 
fatty liver disease (16, 17).
Current knowledge concerning the  impact of BAs and 
their  signaling pathways  on metabolism has  largely  been 
derived from studies in mice. Mouse models are also often 
used  for  initial  testing  of  potential  novel  therapeutics. 
However,  physiologically  very  relevant  differences  exist 
in  the  composition of  the  circulating BA pool between 
humans and mice. The human liver produces two primary 
BAs,  i.e.,  cholic  acid  (CA)  and  chenodeoxycholic  acid 
(CDCA), that can be converted by the microbiome into the 
secondary  deoxycholic  acid  (DCA)  and  lithocholic  acid 
(LCA), respectively. Because the latter is poorly absorbed, 








tively  hydrophobic  CDCA  molecules,  MCA  species  are 
found at the hydrophilic end of the spectrum (19). Conse-
quently, mixed micelles composed of MCAs have a lower 














the  production  of MCAs  in mice  (22). Cyp2c70-deficient 
mice have not been described so far, yet, mice lacking all 
15 Cyp2c genes except Cyp2c44 were shown not to produce 
MCAs  (22).  Conversely,  when  human HepG2  cells  were 
transfected with the murine Cyp2c70 gene, these cells be-
came able to produce MCA and MCA when CDCA and 
UDCA,  respectively,  were  added  to  the  culture  medium 
(22).  CYP2C70  is  therefore  considered  a  6-hydroxylase 
producing MCA from CDCA and MCA from UDCA.
In  the  present  study,  we  employed  CRISPR/Cas9- 
mediated  somatic genome editing  to  inactivate  the gene 
encoding CYP2C70 in the adult mouse liver and, thereby, to 
generate a mouse model with a more human-like BA pool 
composition.  Our  approach  resulted  in  drastically  de-
creased hepatic CYP2C70 levels, an increased contribution 
of  CDCA,  and  a marked  reduction  of MCA but  not  of 
MCA in the BA pool. Using in vivo administration of sta-















(sgRNA)  targeting  the murine Cyp2c70  gene (described below) 
was used to acutely  inactivate this gene in the  liver. To ablate 










Production and purification of the adenovirus





C3-OH C6-OH C7-OH C12-OH
Monohydroxylated
  Lithocholic acid  — — —
Dihydroxylated
  Chenodeoxycholic acid  —  —
  Ursodeoxycholic acid  —  —
  Deoxycholic acid  — — 
  Hyodeoxycholic acid   — —
  Murideoxycholic acid   — —
Trihydroxylated
  Cholic acid  —  
 Muricholic acid    —
 Muricholic acid    —
 Muricholic acid    —
  Hyocholic acid    —
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adenoviral  E1  gene  necessary  for  virus  replication. When  cyto-
pathic effects were present, crude viral  lysate was harvested and 
used to infect fresh HEK293A cells for several rounds of expan-










































coupled  to  a  SCIEX QTRAP  4500 MD  triple  quadrupole mass 
spectrometer  (SCIEX,  Framingham, MA)  and  quantified  using 
D4-labeled BAs as internal standards (26). For fecal BA measure-
ments,  feces  were  dried  and  thoroughly  ground.  About  50 mg 
were incubated for 2 h at 80°C in 1 ml of alkaline methanol and 
purified using C18  cartridges  (Waters, Milford, MA). BAs were 
methylated  and  trimethylsilylated  prior  to  quantification  by 
gas-LC using 5-cholanic acid 7,12 diol as internal standard 
as described (27).











































ples  was  analyzed  by  clustering  all  effective  tags  to  operational 
taxonomic units (OTUs) at 97% similarity. Species were annotated 
based on the OTUs’ representative tags.
Measurement of proteins in liver





thiothreitol  and  alkylation  with  55  mmol/l  of  iodoacetamide, 
solid-phase  extraction  [SPE C18-Aq  (50 mg/1 ml);  Gracepure; 
Thermo Fisher Scientific] was performed for sample clean-up.
LC on a nano-UHPLC system (Ultimate UHPLC focused; Di-
onex; Thermo Fisher Scientific) was performed  to  separate  the 
peptides. The target peptides were analyzed by a triple quadrupole 
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of  stable  isotopically  labeled  standard  peptide  for  CYP2C70 
(TDSSLLSR, PEPotec grade 2; Thermo Fischer Scientific) and 
4  fmol of isotopically labeled concatemer-derived standard pep-
tides  for  CYP7A1  (LSSASLNIR),  CYP8B1  (VVQEDYVLK),  and 
CYP27A1  (LYPVVPTNSR)  (QconCAT  technology, PolyQuant 
GmbH, Germany). The endogenous peptide concentrations were 













levels were calculated by  subtracting  free cholesterol  from total 
cholesterol concentrations.









The  Netherlands)  and  an  oral  dose  of  0.6  mg  cholesterol-D7 
(Cambridge Isotope Laboratories, Inc.) in medium-chain triglyc-



















metric  comparisons  (GraphPad  Software,  San  Diego,  CA), 
whereas the Kruskal-Wallis H test followed by Conover post hoc 
analysis [BrightStat (33)] was used for multiple comparisons. Dif-
ferences  were  considered  statistically  significant  when  P values 
were <0.05.
RESULTS
Inactivation of Cyp2c70 by somatic gene editing induces a 








ing  adenovirus  [hereafter  referred  to  as  Cyp2c70  acute 
knockout  (Cyp2c70ako) mice]  as  compared  with mice  in-
jected with a control virus, confirming highly efficient inac-






fraction  of  UDCA  in  the  BA  pool  also  increased  upon 
Cyp2c70 inactivation, in line with observations in mice lack-






>99% of BAs were  taurine-conjugated  in both groups.  In 
line with the superior capacity of CDCA to promote biliary 
lipid secretion compared with other BA species (35), the 












biome  and BAs, DNA was  extracted  from  freshly  frozen 
fecal pellets and microbial composition was analyzed using 




BA  composition  did  not  translate  into  alterations  of  the 
colonic microbiota in our study.
In vivo, CYP2C70 generates MCA from CDCA in  
a two-step reaction
We performed  a  series  of  experiments  to  quantify  the 
effects of Cyp2c70 on the in vivo conversion of BAs. Because 
UDCA had been suggested as the substrate for the forma-
tion of MCA  in mice  (22), we first  assessed  the  in  vivo 
conversion  of  this  dihydroxylated  BA  into  other  species. 
 at University of G











Supplemental Material can be found at:
Effects of acute inactivation of hepatic Cyp2c70 in mice 295
D4-TUDCA (0.5 mg) was orally administered and bile was 
collected 16 h later. BAs cycle six to ten times per day in 
mice  (36),  which  means  that  the  orally  administered 
D4-TUDCA  had  passed  through  the  intestine  and  liver 
about five to eight times at the moment of bile collection and 
thus had repeatedly been exposed to the actions of hepatic 
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animals  (Fig.  3B),  showing  that  the  in  vivo  turnover  of 
CDCA is much faster than that of UCDA. High levels of 
D4-CDCA were, however,  still detectable  in  the bile of 
Cyp2c70ako mice,  signifying  the  important  role  for  this 
enzyme in the in vivo conversion of CDCA. In line with the 
C6  hydroxylation  activity  of  CYP2C70,  most  of  the  con-
verted tracer was detected in - and MCA in control ani-
mals, whereas concentrations of CDCA-derived D4-MCA 
and D4-MCA were  strongly  reduced  in Cyp2c70ako mice, 
i.e., 50 M versus 450 M in controls. Intriguingly, con-













into  bile  without  being  modified  (Fig.  3C).  In  control 
mice,  on  the  other  hand,  a  substantial  part,  i.e.,  about 
20%, was converted into other BA species by the liver. In 
























cause  the  BA  pool  efficiently  cycles  between  liver  and 
intestine,  this  conversion  rate  will  generate  substantial 
quantities of MCA in the murine BA pool.
Taken together, our data demonstrate that CYP2C70 ex-
erts  epimerase  activity  toward  the  C7  hydroxyl  group  of 
MCA and CDCA. This property of CYP2C70 leads to the 
conversion of MCA  into MCA and,  to  a  lesser  extent, 
















Fig. 2.  Impact  of  Cyp2c70  ablation  on  microbiota. 
Microbial DNA was extracted from freshly frozen feces 
and  16S  ribosomal  DNA  was  sequenced.  The  abun-
dance distribution of the 35 dominant genera among 
all  samples  is displayed  in  a  species  abundance heat 
map (n = 6–8 animals per group).
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0.05  (Mann-Whitney U  test). TCDCA,  taurochenodeoxycholic  acid; MDCA, murodeoxycholic  acid; HCA, 
hyocholic acid; HDCA, hyodeoxycholic acid; CTRL, control.
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No  significant differences  in plasma  lipid  levels were ob-
served between the groups (Table 3). Liver weights were 
not  altered  by Cyp2c70  inactivation,  but  were  slightly  in-
creased in mice receiving the FXR agonist (Fig. 4A). Like-
wise,  hepatic  triglyceride  contents  were  not  affected  in 
Cyp2c70ako  mice  but,  as  expected,  were  reduced  in  the 
groups  treated  with  PX  (Fig.  4B). Hepatic  phospholipid 






content.  Bile  flow  was  not  significantly  altered  upon 








5D).  Secretion of  cholesterol  into  the bile was 1.5-fold 
higher in chow-fed Cyp2c70ako mice as compared with con-
trols,  but  was  not  further  enhanced  by  FXR  stimulation 
(Fig. 5D). The strongly elevated concentrations of CDCA 
in  the  bile  of Cyp2c70ako  mice  (supplemental  Table  S3), 
mainly at the expense of MCA, translated into a markedly 













creted MCAs  that was  lost with  feces decreased upon PX 
treatment  (supplemental  Fig.  S4C).  Furthermore,  no  in-
crease in hepatic CYP2C70 protein levels was detected in 













Also,  in  the  liver, no differences  in mRNA expression of 








in Cyp2c70ako mice  treated with  the FXR agonist  (supple-
mental  Fig.  S5).  In  chow-fed  Cyp2c70ako  mice,  hepatic 





were,  however,  significantly  decreased  (Fig.  6C,  right 
panel). Hepatic mRNA expression of  sterol-12 hydroxy-
lase (Cyp8b1), essential for CA synthesis, was 50% de-





Control (n = 8) Cyp2c70ako (n = 6) Control (n = 6) Cyp2c70ako (n = 7)
Total cholesterol (mmol/l) 2.71 (2.37–3.63) 2.75 (2.57–2.84) 2.49 (2.12–2.80) 2.40 (1.61–3.09)
Free cholesterol (mmol/l) 0.98 (0.88–1.43) 1.19 (0.96–1.52) 1.00 (0.79–1.31) 0.90 (0.66–1.42)
Cholesteryl esters (mmol/l) 1.72 (1.33–2.26) 1.58 (1.05–1.75) 1.33 (1.21–1.75) 1.41 (0.95–1.68)
Triglycerides (mmol/l) 1.27 (0.66–2.89) 1.61 (0.71–2.10) 0.95 (0.72–1.77) 1.12 (0.61–1.54)
Free fatty acids (mmol/l) 0.20 (0.08–0.36) 0.17 (0.15–0.74) 0.32 (0.15–0.56) 0.28 (0.22–0.52)
Alanine aminotransferase (U/l) 76 (42–141) 149 (91–180)a 77 (21–143) 145 (56–293)
Aspartate aminotransferase (U/l) 32 (18–64) 49 (36–60)a 24 (20–38) 49 (17–86)a
Values are presented as median (range) of male mice.
aP < 0.05 versus control (Kruskal-Wallis H test, followed by Conover post hoc comparisons).
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synthesis  pathway  that  produces  CDCA,  was  reduced  in 
chow-fed Cyp2c70ako mice (Fig. 6E, left panel), but was not 
affected by PX. CYP27A1 protein  levels only displayed 
an  insignificant  tendency  toward  a  decrease  in  chow-fed 
Cyp2c70ako mice (Fig. 6E, right panel). Expression of the 
gene  encoding  25-hydroxycholesterol  7-hydroxylase 
(Cyp7b1), another important enzyme in the alternative BA 









In  accordance  with  data  reported  previously  (7),  PX 
treatment markedly reduced fractional cholesterol absorp-
tion in control mice (Fig. 7A), most conceivably due to the 
inferior  cholesterol-solubilizing  properties  of  the  MCA-
dominated hydrophilic BA pool. The more hydrophobic 
BA  pool  in  chow-fed  Cyp2c70ako  mice  did  not  result  in 
higher  fractional  cholesterol  absorption  under  control 
conditions, but did enhance cholesterol absorption upon 
FXR  stimulation.  Fecal  excretion  of  neutral  sterols,  i.e., 
cholesterol and its bacterial metabolites, was not altered in 
Cyp2c70ako mice under control conditions (Fig. 7B). How-










mice  compared  with  controls  did  not  translate  into  re-
duced cholesterol synthesis as determined by the incorpo-
ration  of  labeled  acetate.  The  induction  of  cholesterol 
synthesis upon FXR activation in Cyp2c70ako mice tended 





tion,  which  is  conceivably  attributable  to  stimulatory 
actions of MCAs on the intestinal sterol efflux transporter 





in Cyp2c70ako  mice  under  chow-fed  conditions.  As  ex-
pected,  PX  treatment  strongly  induced TICE  in  control 
mice. The PX-induced stimulation of TICE was  less pro-









 at University of G











Supplemental Material can be found at:
300 Journal of Lipid Research Volume 61, 2020













 at University of G











Supplemental Material can be found at:








 at University of G











Supplemental Material can be found at:







 at University of G











Supplemental Material can be found at:
















In  vitro  experiments  using  the human hepatocyte  cell 





the  enzymatic  activities  of  CYP2C70  in  vivo.  Data  from 
these experiments demonstrate that CYP2C70 exerts a dual 
function, 6-hydroxylation as well as epimerization of the 
C7  hydroxyl  group  from  the   to the   configuration. 
CYP2C70  thereby  not  only  mediates  the  conversion  of 
CDCA into MCA and UDCA into MCA, but also medi-
ates the conversion of MCA into MCA and CDCA into 
UDCA. The  conversion  rate  of  CDCA  into MCA  is  the 
highest,  followed  by MCA  into MCA  and UDCA  into 
MCA, while  only miniscule  amounts  of CDCA  are  con-
verted into UDCA by CYP2C70. The substantially different 
conversion  rates  of  the  reactions  mediated  by  CYP2C70 
may explain why Takahashi et al. (22) did not detect CDCA-
derived MCA  in  their  in  vitro  experiments  with  the 
Cyp2c70-transfected  HepG2  cells  when  D4-CDCA  was 
added to the culture medium. Most likely, the high affinity 
of  CYP2C70  for  CDCA,  combined  with  the  considerable 










Cyp2c70ako mice  in  this  study.  It  is  conceivable  that  some 
functional CYP2C70 was still present in the liver due to he-
patocytes that escaped from genome editing or as a conse-
quence  of  incomplete  inactivation  of  the  Cyp2c70 gene 
resulting  from  in-frame  mutations.  Although  CYP2C70 
protein was  virtually undetectable  in Cyp2c70ako mice,  in-
complete ablation of protein expression is not uncommon 
when using CRISPR/Cas9-mediated somatic genome edit-
ing  in  the  livers of adult mice (23). Extrahepatic expres-
sion of CYP2C70 could also contribute to MCA production. 
We detected Cyp2c70 mRNA in the ileum (Ct-values 33), 
but  levels  were 1,000-fold  lower  than  in  the  liver.  The 





excluded  because  the  turnover  of  MCAs  may  be  slower 
than that of CA. Several attempts have been made to iden-
tify the enzyme(s) involved in MCA production. Mice lack-
ing  seven genes of  the Cyp3a  cluster,  including Cyp3a11, 
produce  normal  amounts  of  MCAs  (45),  whereas  mice 








To  explore  the  physiological  consequences  of  the  hu-
manized BA pool, we quantified cholesterol fluxes in Cyp-
2c70ako  mice  and  controls  upon  pharmacological  FXR 
stimulation.  Intriguingly,  the  bile  formation  process,  as 
such, appeared to be unaffected by Cyp2c70 deletion: bile 











of  the  BA  pool  in  Cyp2c70ako  mice.  Biliary  BA  secretion 
rates  were,  however,  very  similar  between  WT  and  Cyp-
2c70ako mice and fecal BA excretion also did not differ sig-
nificantly between the groups, which makes it unlikely that 








Shp  expression  remained  unchanged  in Cyp2c70ako mice. 
The reason for the reduced expression of Ntcp and Oatp1a1 
therefore remains to be elucidated. Hepatic CYP7A1 pro-





CYP8B1  protein  as  well  as  mRNA  were  reduced  in  Cyp-
2c70ako mice to a similar extent, suggesting that regulation 
took place mainly at the transcriptional level. Our data sug-
gest that the reduced gene expression of Cyp8b1 is due to 
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The  relatively  hydrophobic BA pool  composition  in 
Cyp2c70ako mice did not translate into augmented intestinal 
fractional  cholesterol  absorption.  The mice  were,  how-
ever, fed a standard low-cholesterol diet. It might well be 
that  increasing dietary  cholesterol  content uncovers  an 
enhanced  cholesterol  absorption  capacity  in Cyp2c70ako 
mice. Under  conditions  of  FXR  stimulation, Cyp2c70ako 
mice did  show higher  fractional  cholesterol  absorption 
than controls. In line with previously reported data (7), 
FXR  stimulation  resulted  in  a  strong  increase  of  fecal 




agonist  were  clearly  blunted.  Moreover,  TICE  already 
tended  to  be  lower  in  Cyp2c70ako  mice  compared  with 
controls in the absence of pharmacological FXR activa-
tion.  These  data  are  in  agreement  with  our  previous  
observations  that hydrophilic BAs not only reduce cho-
lesterol absorption efficiency, but also increase active se-
cretion of  cholesterol by enterocytes  into  the  intestinal 
lumen (7).
In addition  to  the presence of  rodent-specific BA spe-
cies in mice, conjugation of BAs also differs between mice 
and humans. In normal mice as well as in our Cyp2c70ako 
mice,  BAs  are  almost  exclusively  conjugated  to  taurine, 
whereas  taurine-  as  well  as  glycine-conjugated  BAs  are 
found  in  humans.  However,  the  physiological  conse-
quences  of  this  difference  are most  conceivably  limited. 





more human-like BA metabolism by  targeting Cyp2c70 in 
adult mice that is anticipated to improve translation of pre-
clinical data  to  the human  situation.  In  vivo  studies with 
stable isotopically labeled BA tracers revealed that, in vivo, 




C7 hydroxyl group of MCA from the  to the  configura-
tion, yielding MCA. Furthermore, the presence of a hu-
man-like BA pool composition in Cyp2c70ako mice resulted 
in  blunted  FXR-induced  cholesterol  disposal  due  to  de-
creased TICE, which emphasizes  the  importance  to care-
fully  consider  the  consequences  of  species-specific  (BA) 
metabolism in preclinical studies.
The  authors  thank  Sander  van  de  Gronden,  Rick  Havinga, 
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